5MPA.SG - Midatech Pharma Plc

Stuttgart - Stuttgart Delayed price. Currency in EUR

Midatech Pharma Plc

65 Innovation Drive
Milton Park
Abingdon OX14 4RQ
United Kingdom
44 1235 888 300
http://www.midatechpharma.com

Sector
Industry
Full-time employees100

Key executives

NameTitlePayExercisedAge
Dr. James Neil Phillips MB, ChB, M.D., MBAChief Exec. Officer & Director626.2kN/A55
Mr. Nicholas John Robbins-Cherry ACA,MBACFO, Company Sec. & Director296.79kN/A48
Dr. Craig Cook MB, BCH, BScHon, DA, M.D., MBACOO & Chief Medical OfficerN/AN/A50
Dr. Dan Palmer Ph.D., MBAChief Scientific OfficerN/AN/AN/A
Mr. Rob Rainey FCA MBA MAHead of Corp. Devel.N/AN/AN/A
Amounts are as of 31 December 2016, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Midatech Pharma PLC, a specialty pharmaceutical company, focuses on the development and commercialization of oncology and other therapeutic products in the United Kingdom, Turkey, other European countries, and the United States. It offers Oravig, an orally dissolving buccal tablet for oral thrush and oropharyngeal candidiasis in adults; Gelclair, an oral rinse gel for the management and relief of pain arising from oral lesions of various etiologies; Zuplenz, an oral soluble film for moderately emetogenic chemotherapy-induced nausea and vomiting, radiotherapy-induced nausea and vomiting, and post-operative nausea and vomiting; and Soltamox, an oral liquid solution of tamoxifen citrate for the prevention of breast cancer. The company also engages in the marketing of Ferralet 90, a prescription iron supplement for the treatment of anemias that are responsive to oral iron therapy; and Aquoral, an artificial saliva spray to provide relief from chemotherapy/radiation therapy. In addition, it is involved in the research and development of various product candidates in the areas of oncology and neuroscience, including ophthalmology; and immunotherapy. Midatech Pharma PLC was founded in 2000 and is headquartered in Abingdon, the United Kingdom.

Corporate governance

Midatech Pharma Plc’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.
By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes